Impact of thyroid dysfunction and diabetes on fibrosis and steatosis stages in metabolic dysfunction associated fatty liver disease
Mohamed W. Saleh, Maysa I. Farghly, Eman Elsebaie, Nessren Mohamed, Eman El-Mankhly · 2025
Read Impact of thyroid dysfunction and diabetes on fibrosis and steatosis stages in metabolic dysfunction associated fatty liver disease by Mohamed W. Saleh, Maysa I. Farghly, Eman Elsebaie, Nessren Mohamed, Eman El-Mankhly (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12706047.txt.
Description
Mohamed Saleh and four co-authors study how thyroid problems and diabetes jointly affect a fatty liver disease. Their study is from two thousand twenty-five, at a hospital in Egypt. Four hundred patients with the liver disease were split into four groups of one hundred. The groups covered all mixes of diabetes and thyroid trouble.
Patients with both conditions had the most advanced liver scarring. Severe fat build-up in the liver was most common in those with thyroid trouble but no diabetes. Low thyroid function, even in mild form, went with higher scarring scores and worse fat levels. Tests included blood work, ultrasound, and a stiffness scan for high-risk patients. The authors urge joint screening of thyroid and sugar in these patients.
Catalog record
| CREATOR | Mohamed W. Saleh, Maysa I. Farghly, Eman Elsebaie, Nessren Mohamed, Eman El-Mankhly |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |